Skip to main content

Table 3 HCWs answers regarding their Knowledge about influenza vaccination (N = 560)

From: Vaccination against influenza among Lebanese health care workers in the era of coronavirus disease 2019

 

#

Correct

Wrong

n(%)

n(%)

Influenza: nature, symptoms and transmission (n = 6 items)

 Influenza, caused by a virus can be a serious disease that can lead to hospitalization and sometimes even death

1

498(88.9%)

62(11.1%)

 Anyone can’t get very sick from flu including people who are healthy

2

451(80.5%)

109(19.5%)

 The signs and symptoms of influenza include fever, headache, sore throat, pain and aches

3

554(98.9%)

6(1.1%)

 You can get flu from patients and coworkers who are sick with flu

4

558(99.6%)

2(0.4%)

 If you become sick with flu, you can spread it to others even if you don’t feel sick

5

422(75.4%)

138(24.6%)

 Symptoms typically appear 8 to 10 days after a person is exposed to influenza

6

283(50.5%)

277(49.5%)

Influenza vaccine safety and importance (n = 5 items)

 The seasonal vaccine protects against the most common influenza viruses including H1N1

1

488(87.1%)

72(12.9%)

 Flu vaccine cannot cause flu

2

361(64.5%)

199(35.5%)

 Flu vaccines are safe, serious problems from a flu vaccine are very rare

3

497(88.8%)

63(11.2%)

 MOPH recommends that HCWs receive influenza vaccine

4

518(92.5%)

42(7.5%)

 By getting vaccinated, you help protect yourself, your family, and your patients.

5

517(92.3%)

43(7.7%)

Influenza vaccine target groups (n = 4 items2)

 Vaccination to prevent flu is particularly important for people who are at high risk of developing serious flu complications

1

540(96.4%)

20(3.6%)

 Pregnant women and people with certain chronic health conditions can get a flu shot

2

382(68.2%)

178(31.8%)

 Children younger than 6 months of age are too young to get a flu should not get flu shot

3

409(73%)

151(27%)

 When vaccine supply is limited, vaccination efforts should be prioritized to:

4

  

 Children aged 6 months through 4 years (59 months);

4a

224(40%)

336(60%)

 People with chronic diseases pulmonary, cardiovascular, renal, hepatic, neurologic

4b

463(82.7%)

97(17.3%)

 People who are immunosuppressed

4c

408(72.9%)

152(27.1%)

 Pregnant woman

4d

199(35.5%)

361(64.5%)

 Health care personnel;

4e

430(76.8%)

130(23.2%)

Administration and storage of vaccine (n = 3 items)

 A trivalent flu shot made using an adjuvant is approved for administration for people ≥65 y of age and older.

1

372(66.4%)

188(33.6%)

 Antibodies develop in the body about 2 weeks after influenza vaccination.

2

465(83.0%)

95(17%)

 Influenza vaccine should be stored at 2 to 8 ° C

3

517(92.3%)

43(7.7%)

Timing of vaccination (n = 3 items)

 Vaccination should occur before onset of influenza activity in the community.

1

545(97.3%)

15(2.7%)

 Vaccination should continue to be offered as long as influenza viruses are circulating

2

427(76.3%)

133(23.8%)

 Annual vaccination is needed to get the “optimal” or best protection against flu

3

523(93.4%)

37(6.6%)

COVID-19 and influenza (n = 3 items)

 Flu vaccine didn’t protect against COVID-19

1

481(85.9%)

79(14.1%)

 Both viruses influenza and COVID-19 are transmitted by respiratory droplets

2

554(98.9%)

6(1.1%)

 COVID-19, and influenza are vastly different pathogens, but there are important areas of overlap

3

459(82%)

101(18%)

  1. N frequency, % percentage